Skip to main content
Heliyon logoLink to Heliyon
. 2021 Apr 17;7(4):e06807. doi: 10.1016/j.heliyon.2021.e06807

Study of correlation between 2D echocardiographic assessment of right ventricle and outcome of acute heart failure patients

Ahmed Magdi Mohamed Genedi a,, Ahmed Mohamed Elzayat b, Mohamed Mohsen Mohamed b, Mahmoud Diaa Elmenshawy b
PMCID: PMC8080040  PMID: 33948519

Abstract

Background

Hospital length of stay (LOS) is a key determinant of heart failure hospitalization costs and performance of medical care quality. Right ventricular (RV) dysfunction predicted poor outcome in patients with acute heart failure (AHF).

Aim

To study the effect of right ventricular function on length of hospital stay as a predictor in patients with acute heart failure.

Methods

A prospective cohort study was conducted in Cardiology Care Units (CCUs) in Zagazig University Hospital and Shark El Madina Hospital from September 2019 to February 2020, we included in this study 99 patients admitted with AHF. Clinical data and baseline RV function assessed by tricuspid annular plane systolic excursion (TAPSE) and S' velocity were collected. Clinical comorbidities including worsening renal function (WRF) were monitored during hospitalization. The primary outcome was hospital LOS.

Results

There was statistically significant correlation between WRF, right ventricular systolic dysfunction identified by TAPSE<16 mm and S' <9.5 cm/s and poor outcome in patients with acute heart failure including prolonged LOS.

Conclusion

Right ventricular (RV) systolic dysfunction as assessed by TAPSE and S' velocity and diastolic dysfunction were independent predictors of longer LOS in AHF patients. WRF had high prevalence among patients with AHF and associated with poor outcome in AHF patients and prolonged LOS.

Keywords: Heart, Failure, Right, Ventricle


Heart, Failure, Right, Ventricle

1. Introduction

Heart failure (HF) is a clinical syndrome that results from pathological and functional disorders characterized by common symptoms (e.g. shortness of breath, swelling of the ankles and fatigue) both with and without signs that result in reduced cardiac performance to meet body's needs, which may be followed by increased intracardiac pressure throughout relaxation or stress [1].

HF normally categorized by left ventricular systolic function as those with normal LVEF [that seem to be ≥50 per cent; HF with preserved EF (HFpEF)] as those with reduced LVEF [that seem to be <40 per cent; HF with decreased EF (HFrEF)] and HF with midrange LVEF [that seem to be ≥40–49 per cent; HF with midrange EF (HFmrEF)] [2].

Acute heart failure (AHF) is a medical entity in which patients develop rapid/progressive deterioration of HF symptoms and signs and considered a major reason of hospital admission in HF patients despite significant advances in diagnosis and management [3].

Length of hospital stay (LOS) is described as the number of days of hospital stay from the first day of admission to the day of discharge. Prolonged long LOS was correlated to poor results in the quality of healthcare and increased mortality rates [4].

Many recognized medical comorbidities for extended LOS involve acute stroke, worsening renal function (WRF), problems of the respiratory system needing special care, atrial fibrillation and nutritional problems [5].

Right ventricular (RV) systolic dysfunction is also said to be in relation with reduced outcomes in HF patients and decreased left ventricular systolic capacity. Although RV dysfunction was investigated in stabilized chronic HF, it had a prognostic significance in AHF patients either with midrange or preserved systolic function [6, 7].

It is generally accepted that there's still a prognostic benefit of RV dysfunction as measured by 2D Transthoracic Echocardiogram (TTE) in estimating longer LOS and worse outcomes in AHF patients [8].

1.1. Aim and objectives

To study the effect of right ventricular function on length of hospital stay as a predictor in patients with acute heart failure.

2. Subjects and methods

2.1. Technical design

Study design: A prospective cohort study, carried out in the period from September 2019 to February 2020 on 99 patients suffering from AHF and admitted in Cardiology care units in Zagazig University Hospital and Shark El Madina Hospital. Patients have been categorized into two groups Group (A) included patients with AHF and normal right ventricular systolic function while Group (B) included patients with AHF with right ventricular systolic dysfunction.

Inclusion criteria included patients with Acute/rapid deterioration in symptoms and/or signs of heart failure that require medical intervention according to latest European Society of Cardiology recommendations published in 2016 and their LOS from 3 to 45 days. On the other side, exclusion criteria included patients suffering from cardiac tamponade or aortic dissection or with evidence of acute coronary syndrome, acute pulmonary embolism. primary/organic tricuspid regurge, LOS less than 3 days or longer than 45 days, End-Stage Renal Disease (ESRD) on regular hemodialysis or who died during hospitalization course.

2.2. Methods

Criteria for admission of AHF patients was established according to the latest recommendations of the European Society of Cardiology (ESC) published in 2016. Detailed full history was taken from all patients with stress on age, sex, occupation, marital status, residence, clinical characteristics and the laboratory data collected during hospital admission.

  • Diabetes mellitus: Defined as having a Hb A1C of 6.5% or greater on two separate occasions according to the American Diabetes Association or the use of blood glucose lowering medications (Insulin or oral anti-diabetic medications) (Classification and Diagnosis of Diabetes, 2015)

  • Hypertension: Hypertension is defined as SBP values ≥ 140 mmHg and/or diastolic BP (DBP) values ≥ 90 mmHg or long history of antihypertension medications.

  • Cigarette smoking: whether smoker history of smoking or current smoker or non-smoker

  • Cerebrovascular disease: ischemic & hemorrhagic stroke or Transient ischemic attack (TIA)

  • Peripheral artery disease

Complete clinical examination was done with specific concentration during the general examination on assessment of the general condition and vital signs. Cardiac examination was done involving inspection, palpation, percussion, and auscultation to detect murmurs and additional sounds and pulmonary rales. We performed some laboratory investigations during patient's hospital stay at (day 1, 3 and 5). Renal function tests (urea & creatinine) were done and WRF was considered as the occurrence of persistent increase ≥0.3 mg/dl or ≥25 % increase in serum creatinine from admission or baseline creatinine in CKD patients [9]. We also performed complete blood count (CBC), cardiac biomarkers (CK-MB & Troponin), electrocardiogram, echocardiography, a conventional echocardiography and Colour Doppler. Doppler and two-dimensional (2D) echocardiography was performed to assess the right ventricular function. Right ventricular systolic function was evaluated by tricuspid annular plane systolic excursion (TAPSE) and abnormal TAPSE <16 mm indicated RV systolic dysfunction. Tissue Doppler-derived tricuspid lateral annular systolic velocity (s′) was assessed and s′ velocity <9.5 cm/s indicated RV systolic dysfunction. Right ventricle diastolic dysfunction was evaluated and a tricuspid E/A ratio <0.8 suggested impaired relaxation and hence diastolic impairment while E/A ratio more than 2.1 and deceleration time <120 m/s indicated restrictive filling and E/E' >6 indicated pseudo-normal RV filling pattern. Right ventricular internal diameters by 2-dimensional echo were done. From apical four chamber view, end diastolic (ED) RV basal diameter of 41 mm indicated dilatation while (ED) RV mid cavity diameter of 35 mm indicated dilatation. End diastolic (ED) RV Longitudinal diameter of 86 mm indicated RV enlargement. Inferior vena cava diameters and changes during respiration were obtained from subcostal view and assessed by motion mode (M-Mode) [10].

2.3. Study outcome

The primary outcome of this research is LOS. It was defined as the average number of days in which the patients stayed in the hospital, from date of entry to the time of discharge. Prolonged length of hospital stay is defined as more than six days based on (2006–2014) data from the Healthcare Cost and Utilization Project (H-CUP) National Emergency Department Survey.

2.3.1. Administrative considerations

Written informed consent was obtained from all participants and the study was approved by the research ethical committee of Faculty of Medicine, Zagazig University Institutional Research Board (IRB). The work has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for studies involving humans.

2.3.2. Statistical analysis

Data were fed to the computer and analyzed using IBM SPSS software package version 20.0. (Armonk, NY: IBM Corp) Qualitative data were described using number and percent. Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR). Significance of the obtained results was judged at the 5% level. The used tests were Chi-square test, Student t-test, Receiver operating characteristic curve (ROC), Regression and Pearson correlation coefficient.

3. Results

A total of 99 AHF patients were initially included in this prospective cohort study, 6 patients were excluded during hospitalization period. Six patients were excluded because they didn't fulfill our exclusion criteria (105 patients initially).

Studied patients had a median age of 65 years old, 58.6% were male, and 41.1% were female as showed in Table 1.

Table 1.

Distribution of the studied cases according to demographic data.

No. %
Sex
Male 58 58.6
Female
41
41.4
Age (years)
Min. – Max. 45.0–88.0
Mean ± SD. 64.06 ± 8.41
Median (IQR) 65.0 (59.0–70.0)

Qualitative data was represented as number and percentage.

Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR).

This table shows distribution of studied cases according to demographic data including age and sex.

All studied patients had prior hypertension, 92.9 % prediabetes/diabetes,60.6 % had a risk factor of smoking, 28% had chronic kidney disease, 79.8% had cardiovascular diseases (either cerebrovascular or coronary artery disease), 31.3% had peripheral arterial insufficiency as showed in Table 2.

Table 2.

Distribution of the studied cases according to risk factors.

Risk Factors No. %
DM 92 92.9
HTN 99 100
Smoker 60 60.6
CKD 28 28
CVD 79 79.8
PVD 31 31.3

This table shows distribution of the studied cases according to risk factors.

52.5% of studied patients had left ventricular systolic function less than 40 %, 25.3% had mid-range systolic function and 22.2 % had preserved systolic function as showed in Table 3.

Table 3.

Distribution of the studied cases according to left ventricular echocardiographic parameters in total sample.

Day 1 No. %
LVEDD
Min. – Max. 52.0–85.0
Mean ± SD. 69.20 ± 7.24
Median (IQR)
69.0 (63.0–75.0)

LVESD

Min. – Max. 37.0–66.0
Mean ± SD. 53.45 ± 7.05
Median (IQR) 55.0 (50.0–56.50)

LVEF

<40% 52 52.5
40–49% 25 25.3
≥50% 22 22.2
Min. – Max. 15.0–66.0
Mean ± SD. 36.35 ± 13.89
Median (IQR) 35.0 (25.0–45.0)

This table shows descriptive analysis for left ventricular echocardiographic parameters of all studied patients.

Forty-eight patients had normal right ventricular systolic function group (A) and fifty-one patients had right ventricular systolic dysfunction group (B) as showed in Table 4.

Table 4.

Distribution of the studied cases according to right ventricular systolic echocardiographic parameters (n = 99).

No. %
TAPSE (mm) (day 1)
<16 51 51.5
≥16 48 48.5
Min. – Max. 9.0–27.0
Mean ± SD. 17.15 ± 3.61
Median (IQR)
15.0 (14.0–19.0)

S' (cm/sec) (day 1)
<9.5 51 51.5
≥9.5 48 48.5
Min. – Max. 8.0–10.0
Mean ± SD. 9.17 ± 0.70
Median (IQR) 9.0 (8.90–9.90)

Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR).

This table shows descriptive analysis of all studied patients according to right ventricular echocardiographic parameters.

Thirty-four patients had right ventricular diastolic dysfunction and all of them were in group (B) as showed in Table 5.

Table 5.

Distribution of the studied cases according to RVDD in day 1.

RVDD No. %
Total (n = 99) 34 34.3
Group A (n = 48) 0 0.0
Group B (n = 51) 34 66.7

Quantitative data represented as number and percentage.

This table shows distribution of patients with right ventricular diastolic dysfunction in the study population.

Table 6 shows that there was high significant difference between both groups regarding poor outcome including prolonged length of hospital stay, need inotropic support and need of mechanical ventilation either invasive or non-invasive in patients with acute heart failure.

Table 6.

Comparison between the two studied groups according to outcome.

Outcome Group A (n = 48)
Group B (n = 51)
Test of Sig. p
No. % No. %
Length of hospital stay (days)
Min. – Max. 3.0–9.0 4.0–14.0 t = 11.838∗ <0.001∗
Mean ± SD. 5.94 ± 1.62 10.31 ± 2.02
Median (IQR) 6.0 (5.0–7.0) 10.0 (10.0–12.0)
Need for inotropic support 11 22.9 46 90.2 χ2 = 45.823∗ <0.001∗
Need for mechanical ventilation 27 56.3 51 100.0 χ2 = 28.320∗ <0.001∗
NICPAP 26 96.3 21 41.2 χ2 = 22.397∗ <0.001∗
Invasive Ventilation 1 3.7 30 58.8

Qualitative data was represented as number and percentage.

Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR).

This table shows that there was high significant difference between both groups regarding poor outcome including prolonged length of hospital stay, need inotropic support and need of mechanical ventilation either invasive or non-invasive in patients with acute heart failure.

The asterisk and hash values are represents statistically significant.

Table 7 shows that there was statistically difference between both groups (patients with right ventricular diastolic dysfunction Vs patients without right ventricular diastolic dysfunction) regarding poor outcome including prolonged length of hospital stay, need for inotropic support and need for mechanical ventilation.

Table 7.

Relation between RVDD and outcome in total sample (n = 99).

Outcome RVDD
Test of Sig. p
Yes (n = 34)
No (n = 65)
No. % No. %
Length of hospital stay (days)
Min. – Max. 6.0–13.0 3.0–14.0 t = 7.572∗ <0.001∗
Mean ± SD. 10.38 ± 1.69 7.05 ± 2.68
Median (IQR) 10.0 (5.0–7.0) 6.0 (10.0–12.0)
Need for inotropic support
34
100.0
44
67.7
χ2 = 13.942∗
<0.001∗
Type for mechanical ventilation
NICPAP 15 44.1 32 72.7 χ2 = 6.555∗ 0.010∗
Invasive Vent 19 55.9 12 27.3

Qualitative data was represented as number and percentage.

Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR).

This table shows that there was statistically difference between both groups (patients with right ventricular diastolic dysfunction Vs patients without right ventricular diastolic dysfunction) regarding poor outcome including prolonged length of hospital stay, need for inotropic support and need for mechanical ventilation.

The asterisk and hash values are represents statistically significant.

Table 8 This table shows statistically significant correlation between worsening in renal function (WRF) and prolonged length of hospital stay and need for inotropic support but there was no statistically significant correlation between WRF and need for mechanical ventilation during hospital stay. Relation between WRF and outcome in study population.

Table 8.

Relation between WRF and outcome in study population.

Outcome WRF
Test of Sig. p
No (n = 37)
Yes (n = 62)
No. % No. %
Length of hospital stay (days)
Min. – Max. 3.0–10.0 4.0–14.0 t = 5.572∗ <0.001∗
Mean ± SD. 6.38 ± 2.18 9.27 ± 2.67
Need inotrope support
11
29.7
46
74.2
χ2 = 18.755∗
<0.001∗
Type of mechanical ventilation
(n = 25)
(n = 53)


NICPAP 19 76.0 28 52.8 χ2 = 3.808 0.051
Invasive Vent 6 24.0 25 47.2

χ2: Chi square test t: Student t-test.

Qualitative data was represented as number and percentage.

Quantitative data were described using range (minimum and maximum), mean, standard deviation, median and interquartile range (IQR).

This table shows statistically significant correlation between worsening in renal function(WRF) and prolonged length of hospital stay and need for inotropic support but there was no statistically significant correlation between WRF and need for mechanical ventilation during hospital stay.

The asterisk and hash values are represents statistically significant.

Table 9 This table shows statistically significant correlation between pneumonia and poor outcome including prolonged length of hospital stay and need for mechanical ventilation.

Table 9.

Relation between pneumonia and outcome in study population.

Outcome Pneumonia
Test of Sig. p
No (n = 43)
Yes (n = 56)
No. % No. %
Length of hospital stay (days)
Min. – Max. 3.0–11.0 4.0–14.0 t = 5.105∗ <0.001∗
Mean ± SD. 6.70 ± 2.39 9.34 ± 2.67
Inotrope support
23
53.5
34
60.7
χ2 = 0.520
0.471
Type of mechanical ventilation
(n = 30)
(n = 48)


NICPAP 27 90.0 20 41.7 χ2 = 18.009∗ <0.001∗
Invasive Vent 3 10.0 28 58.3

This table shows statistically significant correlation between pneumonia and poor outcome including prolonged length of hospital stay and need for mechanical ventilation.

The asterisk and hash values are represents statistically significant.

Table 10 shows univariate regression analysis for the parameters that could prolong hospital stay and shows that (right ventricular systolic dysfunction, pneumonia, WRF and reduced left ventricular ejection fraction LVEF <40%) were the independent predictors for prolonged length of hospital LOS≥ 6 days and multivariate logistic regression analysis shows that right ventricular systolic dysfunction (RVSD) and pneumonia were the most independant parameters that predict prolonged length of hospital stay in patients with acute heart failure. Univariate and multivariate logistic regression analysis for the parameters affecting length of hospital stay.

Table 10.

Univariate and multivariate logistic regression analysis for the parameters affecting length of hospital stay.

Univariate
#Multivariate
p OR (95%C.I) p OR (95%C.I)
RVSD 0.001∗ 32.759∗ (4.166–257.61) 0.029∗ 12.127∗ (1.288–114.15)
Pneumonia 0.001∗ 7.704∗ (2.343–25.328) 0.042∗ 4.753∗ (1.056–21.398)
WRF <0.001∗ 7.773∗ (2.523–23.950) 0.301 2.190 (0.496–9.658)
AF 0.104 2.393 (0.835–6.861)
LVEF <40% 0.009∗ 4.406∗ (1.456–13.334) 0.162 2.736 (0.668–11.213)
Anemia <9 gm/dl 0.090 3.111 (0.839–11.543)

This table shows univariate regression analysis for the parameters that could prolong hospital stay and shows that (right ventricular systolic dysfunction, pneumonia, WRF and reduced LVEF <40%) were the independent predictors for prolonged length of hospital LOS≥ 6 days and multivariate logistic regression analysis shows that right ventricular systolic dysfunction (RVSD) and pneumonia were the most independant parameters that predict prolonged length of hospital stay in patients with acute heart failure.

The asterisk and hash values are represents statistically significant.

Using cut off value ≤ 16 mm for TAPSE as assessment for right ventricular systolic function predicted prolonged length of hospital stay (≥6 days) with positive predictive value of 98.3, sensitivity of 73.42 and specificity of 95 as shown in Table 11.

Table 11.

Agreement (sensitivity, specificity) TAPSE (mm) (day 1) to predict prolonged length of hospital stay (≥6 days).

AUC p 95% C. I
Cut off# Sensitivity Specificity PPV NPV
LL UL
TAPSE (mm) (day 1) 0.845 <0.001∗ 0.741 0.949 ≤16 73.42 95.0 98.3 47.5

Student t-test, Receiver operating characteristic curve (ROC), Regression and Pearson correlation coefficient tests were used.

Using cut off value of 16 mm for TAPSE to diagnose right ventricular systolic function predicted prolonged length of hospital stay (≥6 days) with positive predictive value of 98.3%, sensitivity of 73.42% and specificity of 95%.

The asterisk and hash values are represents statistically significant.

4. Discussion

In this work, we sought to study the relationship between right ventricular dysfunction and length of hospital stay (LOS) in acute heart failure patients.

Establishing such relationship could urge physicians to give more attention to right ventricular dysfunction aiming at reducing length of hospital stay (LOS) in such patients.

Clement and colleagues performed a study to prove that RV dysfunction is an important indicator for adverse outcomes in patients with dilated cardiomyopathy (DCM). 34 patients with RV dysfunction identified as TAPSE ≤15 mm; 102 patients (group 2) retained RV function [12].

In disagreement with our study, Clement Vennera et al, included more male patients (about two-third) compared to 58.6% in our study. Mean age of studied patients was 64.06 ± 8.41 years in our study compared to 59.0 ± 13.2 years in Clement Vennera et al study.

On the other hand our study was performed on patients with broad range of left ventricular systolic function either preserved, mid-range and reduced left ventricular systolic function but Clement Vennera, et al study restrict their study for patients with acute heart failure with reduced left ventricular systolic function (LVEF <45 %).

Ghio and colleagues performed a study to prove that RV dysfunction estimated by TAPSE had poor outcomes in heart failure patients with decreased left ventricular systolic function LVEF<35% [13].

Our study was concordant with these results in considering TAPSE as important tool for assessment right ventricular systolic function and independent prognostic factor for patients with AHF with reduced left ventricular systolic function LVEF <35%.

Ghio S, et al study was carried out on patients with reduced left ventricular systolic function but our study included broad range LV systolic function and in our study we also assessed right ventricular systolic function by another parameter (S' velocity) due to limitations of TAPSE and also assessed right ventricular diastolic dysfunction which was't investigated in Ghio S, et al study.

In a study performed by Damy and colleagues, the prognosis of RV function was assessed by TAPSE in congestive heart failure patients (CHF) with manifestations of a variety of symptoms (LVEF) unidentified [14].

Our study was also in agreement with these results that proved that, in patients with CHF, low values for TAPSE are common, especially in those with reduced LVEF and considered an important prognostic factor for patients with acute decompensated heart failure.

Thomas and colleagues conducted a meta-analysis trial to analyze the impact of right ventricular dysfunction measured by TAPSE <16 mm, RV S < 9.5 and fractional area change (FAC) < 35% and pulmonary hypertension (PH) with prognosis involving rates of mortality and morbidity in AHF patients with intact systolic function (HFpEF) [11].

This meta-analysis study investigated the influence of RV dysfunction measured by various echocardiographic parameters and its relationship to poor outcomes in HFpEF patients.

In this meta-analysis with strict HFpEF parameters, the incidence of RV dysfunction was 28 per cent for TAPSE, 18 per cent for fractional area change (FAC) and 21 per cent for RV S. TAPSE (HR 1.26/5 mm decrease, P < 0.0001), FAC ((HR 1.15/5 percent decrease; P < 0.0001), increase; P < 0.0001) were both inevitably correlated with fatalities. HRs for RV S have not been registered [11].

Our study was concordant with the study of Thomas and colleagues that proved that RV dysfunction was highly prevalent in HFpEF. The prevalence of RV dysfunction was dependent on the method and cut-offs used for its assessment and associated with poor outcome in patients with heart failure with preserved systolic function (HFpEF) but our study was performed on patients with HF either with preserved or mid-range and reduced LVEF.

This study presented data on the RV feature in HFpEF vs. HFrEF, referring to a control group without HF, all prospectively selected from a diverse ethnic groups Asian community that used a standard methodology. The incidence of RV dysfunction, measured by TAPSE or RV deformation scanning, reached up to 42% in HFpEF, 4 times the prevalence of controls, but also more in HFrEF in 2/3 of patients.

In their study, Yamin et al, 2016 sought to establish the relationship between RV dysfunction and prolonged LOS in patients with ADHF and its prognostic value. They recruited 259 patients with ADHF, on multivariate Cox regression analysis, RV function (HR = 5.965,95%CI = 4.402–8.082,P = 0.002) was associated with longer LOS. Also they found that based on median TAPSE<16 mm had significantly longer LOS compared to those with TAPSE>16 mm.

They concluded that RV dysfunction, WRF and malnutrition are important predictors of LOS in ADHF patients [15].

Their results come in agreement with those of our study regarding RV dysfunction and WRF. However, we did not study malnutrition in our cohort of patients.

In their review of 105 cases with systolic HF, Yu and Sanderson did a study which revealed right ventricular diastolic dysfunction (RVDD) to be occurring in 21 percent of participants as evaluated by echocardiography. Even though a low-powered research, the researchers concluded that RVDD was just an independent indicator of nonfatal hospitalizations for unstable angina or HF, while it was not found to become a predictive value for mortality, alone or in association with left ventricular diastolic dysfunction [16].

Our study was concordant with the study of Yu and Sanderson regarding RVDD considered as independent prognostic factor in patient with acute heart failure and related to prolonged LOS.

The greater prognostic value of the TAPSE and S ′velocity relative to other echocardiographic metrics of the RV systolic function seems to be that the decreased TAPSE and S′ velocity truly represents a significant impairments of RV function, since the systolic shortening of the RV from base to apex gives evidence on not only the process of emptying of the RV but also on the driving force acting on the systolic.

Our findings regarding pneumonia were concordant with Alexander Jobs, et al that performed a study on 1939 patients with acute decompensating heart failure (ADHF) this study carried out in department of cardiology at Germany and they proved that concomitant pneumonia was relatively common in patients with ADHF and associated with poor outcome including longer length of hospital stay (LOS) and increased rates of in-hospital mortality [17].

4.1. Limitations

  • 1.

    A major limitation of this study was the small sample size and the fact that it was carried out in two centers in Egypt. Further longer sample size multi-centre studies are needed to further consolidate our findings.

  • 2.

    Variables influencing hospital LOS in HF include a broad range of socio-cultural and economic factors outside the scope of this study, were not investigated.

  • 3.

    We did not assess other factors that were difficult to measure such as patients‘ compliance, mobility, readiness for discharge, and factors related with healthcare environment.

  • 4.

    Biomarker NT-pro BNP and other sofisticated laboratory or radiological investigations to assess pneumonia and worsening in renal function were not assessed in this study, this could have shorter LOS and guided treatment.

5. Conclusion and recommendations

RV systolic dysfunction as measured by TAPSE and S ′velocity had been an important indicator of long LOS in ADHF patients. RVDD has a strong association with poor outcomes in patients with AHF. WRF had an increased incidence in patients with AHF and correlated with low outcomes in patients with AHF and extended LOS. Right side evaluation in 2-D echocardiography must be regularly conducted as a left side evaluation. RV dysfunction must be treated as left ventricular malfunction.

Declarations

Author contribution statement

Ahmed Magdi Mohamed Genedi: Performed the experiments; Wrote the paper.

Ahmed Mohamed Elzayat: Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data.

Mohamed Mohsen Mohamed: Performed the experiments; Analyzed and interpreted the data.

Mahmoud Diaa Elmenshawy: Conceived and designed the experiments.

Funding statement

This work was supported by Zagazig University, Egypt.

Data availability statement

Data will be made available on request.

Declaration of interests statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Acknowledgements

The authors are grateful for the patients without whom this study would not have been done.

References

  • 1.Wang T.J., Evans J.C., Benjamin E.J., Levy D.A., LeRoy E.C., Vasan R.S. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977–982. doi: 10.1161/01.CIR.0000085166.44904.79. [DOI] [PubMed] [Google Scholar]
  • 2.Butler J.A., Fonarow G.C., Zile M.R., Lam C.S., Roessig L., Schelbert E.B. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC (J. Am. Coll. Cardiol.) 2014;2:97–112. doi: 10.1016/j.jchf.2013.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wright S.P., Verouhis D., Gamble G., Swedberg K., Sharpe N., Doughty R.N. Factors influencing the length of hospital stay of patients with heart failure. Eur. J. Heart Fail. 2003;5:201–209. doi: 10.1016/s1388-9842(02)00201-5. [DOI] [PubMed] [Google Scholar]
  • 4.Allen L.A., Smoyer K.E., Wilson K.L., Smith D.M., Agodoa I.R. The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J. Med. Econ. 2013;16:43–54. doi: 10.3111/13696998.2012.726932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brown A.M., Cleland J.G. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur. Heart J. 1998;19:1063–1069. [PubMed] [Google Scholar]
  • 6.Damy T.H., Kallvikbacka A.N., Goode K.E., Khaleva O.L., Lewinter C.H., Hobkirk J.A. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J. Card. Fail. 2012;18:216–225. doi: 10.1016/j.cardfail.2011.12.003. [DOI] [PubMed] [Google Scholar]
  • 7.Lang R.M., Badano L.P., Moravi V.I., Afilalo J.O., Armstrong A.N., Ernande L.A. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2015;28:1–39. doi: 10.1016/j.echo.2014.10.003. e14. [DOI] [PubMed] [Google Scholar]
  • 8.Verhaert D.A., Mullens W.I., Borowski A.L., Popović Z.B., Curtin R.J., Thomas J.D. Right ventricular response to intensive medical therapy in advanced decompensated heart failure. Circ. Heart Fail. 2010;3:340–346. doi: 10.1161/CIRCHEARTFAILURE.109.900134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Molitoris B.A., Levin A.D., Warnock D.G., Joannidis M.I., Mehta R.L., Kellum J.A. Improving outcomes of acute kidney injury: report of an initiative. Nat. Clin. Pract. Nephrol. 2007;3:439–442. doi: 10.1038/ncpneph0551. [DOI] [PubMed] [Google Scholar]
  • 10.Rudski Lawrence G., Lai Wyman W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010;23:685–713. doi: 10.1016/j.echo.2010.05.010. [DOI] [PubMed] [Google Scholar]
  • 11.Gorter Thomas M., Hoendermis Elke S., van Veldhuisen Dirk J., Voors Adriaan A., Lam Carolyn S.P., Geelhoed Bastiaan. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur. J. Heart Fail. 2016 Dec;18(12):1472–1487. doi: 10.1002/ejhf.630. [DOI] [PubMed] [Google Scholar]
  • 12.Florea V.G., Florea N.D., Coats A.J., Gibson D.G., Hodson M.E., Henein M.Y. Right ventricular dysfunction in adult severe cystic fibrosis. Chest. 2000;118:1063–1068. doi: 10.1378/chest.118.4.1063. [DOI] [PubMed] [Google Scholar]
  • 13.Dourvas I.N., Parharidis G.E., Efthimiadis G.K., Karvounis H.I., Gemitzis K.D., Styliadis I.H. Right ventricular diastolic function in patients with chronic aortic regurgitation. Am. J. Cardiol. 2004;93:115–117. doi: 10.1016/j.amjcard.2003.09.022. [DOI] [PubMed] [Google Scholar]
  • 14.Cicala S., Galderisi M., Caso P., Petrocelli A., D'Errico A., De Divitiis O. Right ventricular diastolic dysfunction in arterial systemic hypertension: analysis by pulsed tissue Doppler. Eur. J. Echocardiogr. 2002;3:135–142. doi: 10.1053/euje.2001.0124. [DOI] [PubMed] [Google Scholar]
  • 15.Yamin P.P., Raharjo S.B., Putri V.K., Hersunarti N. Right ventricular dysfunction as predictor of longer hospital stay in patients with acute decompensated heart failure: a prospective study in Indonesian population. Cardiovasc. Ultrasound. 2016 Jul 11;14(1):25. doi: 10.1186/s12947-016-0069-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yu C.M., Sanderson J.E., Chan Skiva, Yeung Leata, Hung Y.T., Woo K.S. Right ventricular diastolic dysfunction in heart failure. Circulation. 1996;93:1509–1514. doi: 10.1161/01.cir.93.8.1509. [DOI] [PubMed] [Google Scholar]
  • 17.Alexander Jobs, Simon Ronja, de Waha Suzanne, Rogacev Kyrill, Alexander Katalinic, Babaev Valentin, Thiele Holger. Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients. Eur. Heart J. – Acute Cardiovasc. Care. 2017;30 doi: 10.1177/2048872617700874. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES